Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Generation 2 Dual GLP-1/GIP Agonists (Tirzepatide) Tirzepatide was the first dual-agonist incretin peptide to reach advanced clinical research
[DOI] [PMC free article] [PubMed] [Google Scholar] 21.Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A
Alternative Weight Management Strategies During Perimenopause Whilst GLP-1 medications may offer benefits for some women, comprehensive lifestyle approaches remain the foundation of weight management during perimenopause
S., Bergenstal, R
Key Takeaway: Tirzepatide is unique because it targets two different hormone receptors (GLP-1 and GIP) to support metabolic health and appetite regulation more effectively than single-hormone medications
In patients with depression, the reward learning process is disrupted, and impaired reward learning is thought to lead to depressive mood and behavior (Fletcher and Reback, 2015)
US$ 20.70
US$ 24.95
US$ 27.47
